ASPC 2019 Congress on CVD Prevention
Avatar

REDUCE-IT and Treating Beyond LDL-C Lowering

By ASPC 2019 Congress on CVD Prevention FEATURING Deepak Bhatt
By ASPC 2019 Congress on CVD Prevention FEATURING Deepak Bhatt
0 views
August 9, 2019
Comments 0
Login to view comments. Click here to Login

Featured Video

26:13
Lilly Diabetes

A Journey through Five Phase 3 Clinical Trials for a T2D Incretin Me…

Feat. B. Hirsch

Featured Video

18:06
Lilly Obesity

Getting Patients Started with an Obesity Treatment Option for Adults

Feat. E. Lazarus

Recommended

AUTOPLAY
12:04
Stephen Kopecky

Role of PCSK9 Inhibitors in Diabetes

28:13
National Lipid Association

New Insights into Triglyceride Therapy and the Role of Omega-3 Fatty…

Feat. R. Mason
59:01
The North American Thrombosis Forum (NATF)

Recent Cholesterol Guidelines and Integration into Clinical Practice

Feat. J. Plutzky, L. Braun, J. Ross
18:43
Canadian Collaborative Research Network

Lp(a): When to Measure it and What to Do About it

Feat. M. O'Donoghue
19:16
The Texas Heart Institute

Role of Coronary Calcification and Risk Stratification

Feat. E. Hernandez
08:44
AHA 2022 Conference Coverage

AHA 2022: Cardiovascular Benefit of Lowering LDL Cholesterol Below 4…

Feat. N. Marston
21:27
Scripps Health

Lipids Update: Current Guidelines for Lipid Management

Feat. S. R. Mehta
14:50
AHA 2022 Conference Coverage

AHA 2022: Long-Term Efficacy and Safety of Inclisiran in Patients Wi…

Feat. K. Ray
24:02
Complex Coronary Cases

Updated Lipid Guidelines and Therapy

Feat. I. Fergus
19:09
ACC 2023 Conference Coverage

ACC 2023: Management of Statin Side Effects and How to Keep Them on …

Feat. J. Saseen
34:20
Cedars Sinai

Cardiology’s Biggest Controversy: The Lumen or the Wall - the Curiou…

Feat. J. Forrester
45:45
Houston Methodist DeBakey Heart and Vascular Center

Directions of Cardiology in the Next Decade: 2022-2032

Feat. E. Braunwald
31:02
Scripps Health

How Do I Reverse Coronary Plaque?

Feat. C. J. Suhar
31:27
Scripps Health

Evaluate the Horrible Cholesterol Lp(a): Prevalence, Impact and Nove…

Feat. N. Lepor
19:48
ACC 2022 Conference Coverage

ACC 2022: Updates on Lowering LDL-C in Secondary Prevention - "…

Feat. R. Giugliano
39:44
The Texas Heart Institute

Lipid Lowering Therapies: Where Did We Start, Where We Are Now and W…

Feat. S. Virani
10:59
Mayo Clinic Proceedings

What Is the Effect of Omega-3 on Cardiovascular Outcomes? Should Thi…

Feat. C. Lavie
42:25
Piedmont Heart Institute

Peripheral Arterial Disease: How To Prevent? When To Diagnose? How T…

Feat. A. Klein
12:26
CVC 2018

Statin & Warfarin Induce Accelerated Atherosclerosis and Are Con…

22:22
Practical Ways to Achieve Targets in Diabetes Care

Omega-3 Fatty Acids and Cardiovascular Outcomes: Anatomy of a Fish T…

Feat. S. Nissen